6PGD-IN-S3
CAS No. 5539-66-2
6PGD-IN-S3( 6PGD Inhibitor S3 | S3 | Danthron methyl derivative )
Catalog No. M27840 CAS No. 5539-66-2
6PGD-IN-S3 is an inhibitor of 6-phosphogluconate dehydrogenase (6PGD).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name6PGD-IN-S3
-
NoteResearch use only, not for human use.
-
Brief Description6PGD-IN-S3 is an inhibitor of 6-phosphogluconate dehydrogenase (6PGD).
-
Description6PGD-IN-S3 is an inhibitor of 6-phosphogluconate dehydrogenase (6PGD).
-
In Vitro——
-
In Vivo——
-
Synonyms6PGD Inhibitor S3 | S3 | Danthron methyl derivative
-
PathwayMetabolic Enzyme/Protease
-
TargetDehydrogenase
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number5539-66-2
-
Formula Weight254.241
-
Molecular FormulaC15H10O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOc1cccc2C(=O)c3cccc(O)c3C(=O)c12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.H Kikukawa, et al. Production of cis-11-eicosenoic acid by Mortierella fungi. J Appl Microbiol. 2015 Mar;118(3):641-7.
molnova catalog
related products
-
11β-HSD1 inibitor 17
11β-HSD1 inibitor 17 is an inhibitor of 11β-hydroxysteroid dehydrogenase (11β-HSD1).
-
GSK864
GSK864 is an IDH1 mutant inhibitor that inhibits IDH1 mutants R132C, R132H, and R132G, and is used in the study of cardiovascular and oncology diseases.
-
CBR-5884
CBR-5884 is an ?selective, active of phosphoglycerate dehydrogenase (PHGDH) inhibitor with an IC50 of 33 μM.?CBR-5884 inhibits de novo serine synthesis in cancer cells and is selectively toxic to cancer cell lines with high serine biosynthetic activity.?
Cart
sales@molnova.com